These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12626574)

  • 1. Immunogene therapy of tumors with vaccine based on xenogeneic epidermal growth factor receptor.
    Lu Y; Wei YQ; Tian L; Zhao X; Yang L; Hu B; Kan B; Wen YJ; Liu F; Deng HX; Li J; Mao YQ; Lei S; Huang MJ; Peng F; Jiang Y; Zhou H; Zhou LQ; Luo F
    J Immunol; 2003 Mar; 170(6):3162-70. PubMed ID: 12626574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Active antitumor immunity elicited by vaccine based on recombinant form of epidermal growth factor receptor.
    Hu B; Wei Y; Tian L; Zhao X; Lu Y; Wu Y; Yao B; Liu J; Niu T; Wen Y; He Q; Su J; Huang M; Lou Y; Luo Y; Kan B
    J Immunother; 2005; 28(3):236-44. PubMed ID: 15838380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunogene therapy of cancer with vaccine on the basis of chicken homologous matrix metalloproteinase-2.
    Su JM; Wei YQ; Tian L; Zhao X; Yang L; He QM; Wang Y; Lu Y; Wu Y; Liu F; Liu JY; Yang JL; Lou YY; Hu B; Niu T; Wen YJ; Xiao F; Deng HX; Li J; Kan B
    Cancer Res; 2003 Feb; 63(3):600-7. PubMed ID: 12566302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single heteroclitic epitope determines cancer immunity after xenogeneic DNA immunization against a tumor differentiation antigen.
    Gold JS; Ferrone CR; Guevara-Patiño JA; Hawkins WG; Dyall R; Engelhorn ME; Wolchok JD; Lewis JJ; Houghton AN
    J Immunol; 2003 May; 170(10):5188-94. PubMed ID: 12734366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy of tumors with vaccine based on quail homologous vascular endothelial growth factor receptor-2.
    Liu JY; Wei YQ; Yang L; Zhao X; Tian L; Hou JM; Niu T; Liu F; Jiang Y; Hu B; Wu Y; Su JM; Lou YY; He QM; Wen YJ; Yang JL; Kan B; Mao YQ; Luo F; Peng F
    Blood; 2003 Sep; 102(5):1815-23. PubMed ID: 12750177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunotherapy of tumors with a recombinant xenogeneic endoglin as a model antigen.
    Tan GH; Wei YQ; Tian L; Zhao X; Yang L; Li J; He QM; Wu Y; Wen YJ; Yi T; Ding ZY; Kan B; Mao YQ; Deng HX; Li HL; Zhou CH; Fu CH; Xiao F; Zhang XW
    Eur J Immunol; 2004 Jul; 34(7):2012-21. PubMed ID: 15214049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The mechanism of anti-tumor immune response against mouse melanoma to xenogeneic vaccination].
    Luo F; Mao YQ; Kan B; He QM; Jiang Y; Peng F; Yang L; Tian L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):757-60. PubMed ID: 15573746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3.
    Lou YY; Wei YQ; Yang L; Zhao X; Tian L; Lu Y; Wen YJ; Liu F; Huang MJ; Kang B; Xiao F; Su JM; He QM; Xie XJ; Mao YQ; Lei S; Liu JY; Lou F; Zhou LQ; Peng F; Jiang Y; Hu B
    Immunol Invest; 2002 Feb; 31(1):51-69. PubMed ID: 11990463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular immunotherapy using irradiated lung cancer cell vaccine co-expressing GM-CSF and IL-18 can induce significant antitumor effects.
    Tian H; Shi G; Yang G; Zhang J; Li Y; Du T; Wang J; Xu F; Cheng L; Zhang X; Dai L; Chen X; Zhang S; Yang Y; Yu D; Wei Y; Deng H
    BMC Cancer; 2014 Jan; 14():48. PubMed ID: 24475975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A DNA vaccine encoding the extracellular domain of porcine endoglin induces antitumor immunity in a mouse colon carcinoma model].
    Jiao JG; Zhang YD; Li YN
    Ai Zheng; 2005 Oct; 24(10):1179-83. PubMed ID: 16219129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary antitumor immunity induced by plasmid DNA encoding secreted and cytoplasmic human ErbB-2.
    Piechocki MP; Pilon SA; Wei WZ
    J Immunol; 2001 Sep; 167(6):3367-74. PubMed ID: 11544327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2.
    Yi T; Wei YQ; Tian L; Zhao X; Li J; Deng HX; Wen YJ; Zou CH; Tan GH; Kan B; Su JM; Jiang Y; Mao YQ; Chen P; Wang YS
    Cancer Gene Ther; 2007 Feb; 14(2):158-64. PubMed ID: 17124509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T lymphocyte responses against lung cancer induced by recombinant truncated mouse EGFR.
    Hu B; Wei YQ; Tian L; Zhao X; Lu Y; Wu Y; Yao B; Zhang XW
    Cancer Immunol Immunother; 2006 Apr; 55(4):386-93. PubMed ID: 16235052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors].
    Liu D; Tang L; Zhou CC; Tan LS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor mechanism of recombinant murine interleukin-12 vaccine.
    Yin X; Yan X; Yang Q; Cao H; Liang H
    Cancer Biother Radiopharm; 2010 Jun; 25(3):263-8. PubMed ID: 20578831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY; Xu YF; Fan DS; Peng QL; Zhang T; Xu XM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct; 29(5):584-91. PubMed ID: 18051710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mammary carcinoma development in HER-2/neu transgenic mice through induction of autoimmunity by xenogeneic DNA vaccination.
    Pupa SM; Iezzi M; Di Carlo E; Invernizzi A; Cavallo F; Meazza R; Comes A; Ferrini S; Musiani P; Ménard S
    Cancer Res; 2005 Feb; 65(3):1071-8. PubMed ID: 15705909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.